What if the body’s own cells could be reprogrammed as tiny factories, producing exactly the protein a patient needs at the right time, in the right amount?
As people age, their risk of joint inflammation rises — not just because joints wear down, but because the body quietly loses one of its own braking systems.
Instead of targeting amyloid or tau — the usual suspects in Alzheimer’s research — scientists focused on a neuropeptide that had been sitting in the background for decades.